GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Respiratory market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Respiratory market reports here.

NEW Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Interstitial Lung Diseases (Diffuse Parenchymal...

NEW Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lung Infections pipeline landscape. The report provides comprehensive information on...

NEW Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lung Injury pipeline landscape. The report provides comprehensive information on...

NEW Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • April 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Drugs In Development, 2022, provides an overview of the Bronchopulmonary Dysplasia (Respiratory) pipeline landscape. Bronchopulmonary dysplasia (BPD)...

NEW Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • April 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cough - Drugs In Development, 2022, provides an overview of the Cough (Respiratory) pipeline landscape. Cough is a reflex action...

NEW Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update,...

Pulmonary Fibrosis – Global Clinical Trials Review, 2022

  • $2,500
  • January 2022
GlobalData's clinical trial report, “Pulmonary Fibrosis - Global Clinical Trials Review, 2022" provides an overview of Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the...

Cystic Fibrosis – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
This report provides top-line data relating to the clinical trials on cystic fibrosis. This report includes an overview of trials count and their average enrollment in top countries conducted globally....

Malignant Pleural Effusion – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021" provides an overview of Malignant Pleural Effusion Clinical trials scenario. This report provides top line data...

Obstructive Sleep Apnea – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data...